JPMorgan Chase reaffirmed their neutral rating on shares of BASF (OTCMKTS:BASFY) in a report published on Friday morning.
A number of other equities analysts have also recently weighed in on the stock. Zacks Investment Research cut shares of BASF from a buy rating to a hold rating in a research note on Wednesday. ValuEngine cut shares of BASF from a buy rating to a hold rating in a research note on Monday, April 2nd. Finally, HSBC raised shares of BASF from a reduce rating to a hold rating in a research note on Tuesday, February 13th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the stock. The company has an average rating of Hold and an average target price of $31.00.
Get BASF alerts:
Shares of OTCMKTS:BASFY traded up $0.11 on Friday, reaching $26.18. 195,164 shares of the company were exchanged, compared to its average volume of 362,827. The company has a quick ratio of 1.40, a current ratio of 2.09 and a debt-to-equity ratio of 0.45. BASF has a 1-year low of $22.98 and a 1-year high of $30.22. The stock has a market cap of $95,781.18, a PE ratio of 14.38, a price-to-earnings-growth ratio of 2.03 and a beta of 1.17.
BASF (OTCMKTS:BASFY) last posted its quarterly earnings results on Thursday, February 22nd. The basic materials company reported $0.43 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.43. BASF had a net margin of 9.41% and a return on equity of 18.50%. The business had revenue of $18.96 billion for the quarter. equities analysts anticipate that BASF will post 2.05 earnings per share for the current year.
BASF SE operates as a chemical company worldwide. It operates through five segments: Chemicals, Performance Products, Functional Materials & Solutions, Agricultural Solutions, and Oil & Gas. The Chemicals segment offers solvents, plasticizers, monomers, and glues, as well as raw materials for detergents, plastics, textile fibers, paints and coatings, crop protection products, and medicines.